Global Duchenne Muscular Dystrophy Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Duchenne Muscular Dystrophy market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Duchenne Muscular Dystrophy market are covered in Chapter 9:
Taiho Pharmaceutical
Catabasis Pharmaceuticals
Italfarmaco
Santhera Pharmaceuticals/ReveraGen BioPharma
FibroGen
Capricor
Pfizer
Daiichi Sankyo
PTC Therapeutics
Sarepta Therapeutics
Nippon Shinyaku (NS Pharma)
In Chapter 5 and Chapter 7.3, based on types, the Duchenne Muscular Dystrophy market from 2017 to 2027 is primarily split into:
Deflazacort
Prednisone
Others
In Chapter 6 and Chapter 7.4, based on applications, the Duchenne Muscular Dystrophy market from 2017 to 2027 covers:
Male
Female
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Duchenne Muscular Dystrophy market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Duchenne Muscular Dystrophy Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Duchenne Muscular Dystrophy market are covered in Chapter 9:
Taiho Pharmaceutical
Catabasis Pharmaceuticals
Italfarmaco
Santhera Pharmaceuticals/ReveraGen BioPharma
FibroGen
Capricor
Pfizer
Daiichi Sankyo
PTC Therapeutics
Sarepta Therapeutics
Nippon Shinyaku (NS Pharma)
In Chapter 5 and Chapter 7.3, based on types, the Duchenne Muscular Dystrophy market from 2017 to 2027 is primarily split into:
Deflazacort
Prednisone
Others
In Chapter 6 and Chapter 7.4, based on applications, the Duchenne Muscular Dystrophy market from 2017 to 2027 covers:
Male
Female
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Duchenne Muscular Dystrophy market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Duchenne Muscular Dystrophy Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 DUCHENNE MUSCULAR DYSTROPHY MARKET OVERVIEW
1.1 Product Overview and Scope of Duchenne Muscular Dystrophy Market
1.2 Duchenne Muscular Dystrophy Market Segment by Type
1.2.1 Global Duchenne Muscular Dystrophy Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Duchenne Muscular Dystrophy Market Segment by Application
1.3.1 Duchenne Muscular Dystrophy Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Duchenne Muscular Dystrophy Market, Region Wise (2017-2027)
1.4.1 Global Duchenne Muscular Dystrophy Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Duchenne Muscular Dystrophy Market Status and Prospect (2017-2027)
1.4.3 Europe Duchenne Muscular Dystrophy Market Status and Prospect (2017-2027)
1.4.4 China Duchenne Muscular Dystrophy Market Status and Prospect (2017-2027)
1.4.5 Japan Duchenne Muscular Dystrophy Market Status and Prospect (2017-2027)
1.4.6 India Duchenne Muscular Dystrophy Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Duchenne Muscular Dystrophy Market Status and Prospect (2017-2027)
1.4.8 Latin America Duchenne Muscular Dystrophy Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Duchenne Muscular Dystrophy Market Status and Prospect (2017-2027)
1.5 Global Market Size of Duchenne Muscular Dystrophy (2017-2027)
1.5.1 Global Duchenne Muscular Dystrophy Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Duchenne Muscular Dystrophy Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Duchenne Muscular Dystrophy Market
2 INDUSTRY OUTLOOK
2.1 Duchenne Muscular Dystrophy Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Duchenne Muscular Dystrophy Market Drivers Analysis
2.4 Duchenne Muscular Dystrophy Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Duchenne Muscular Dystrophy Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Duchenne Muscular Dystrophy Industry Development
3 GLOBAL DUCHENNE MUSCULAR DYSTROPHY MARKET LANDSCAPE BY PLAYER
3.1 Global Duchenne Muscular Dystrophy Sales Volume and Share by Player (2017-2022)
3.2 Global Duchenne Muscular Dystrophy Revenue and Market Share by Player (2017-2022)
3.3 Global Duchenne Muscular Dystrophy Average Price by Player (2017-2022)
3.4 Global Duchenne Muscular Dystrophy Gross Margin by Player (2017-2022)
3.5 Duchenne Muscular Dystrophy Market Competitive Situation and Trends
3.5.1 Duchenne Muscular Dystrophy Market Concentration Rate
3.5.2 Duchenne Muscular Dystrophy Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL DUCHENNE MUSCULAR DYSTROPHY SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Duchenne Muscular Dystrophy Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Duchenne Muscular Dystrophy Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Duchenne Muscular Dystrophy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Duchenne Muscular Dystrophy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Duchenne Muscular Dystrophy Market Under COVID-19
4.5 Europe Duchenne Muscular Dystrophy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Duchenne Muscular Dystrophy Market Under COVID-19
4.6 China Duchenne Muscular Dystrophy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Duchenne Muscular Dystrophy Market Under COVID-19
4.7 Japan Duchenne Muscular Dystrophy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Duchenne Muscular Dystrophy Market Under COVID-19
4.8 India Duchenne Muscular Dystrophy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Duchenne Muscular Dystrophy Market Under COVID-19
4.9 Southeast Asia Duchenne Muscular Dystrophy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Duchenne Muscular Dystrophy Market Under COVID-19
4.10 Latin America Duchenne Muscular Dystrophy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Duchenne Muscular Dystrophy Market Under COVID-19
4.11 Middle East and Africa Duchenne Muscular Dystrophy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Duchenne Muscular Dystrophy Market Under COVID-19
5 GLOBAL DUCHENNE MUSCULAR DYSTROPHY SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Duchenne Muscular Dystrophy Sales Volume and Market Share by Type (2017-2022)
5.2 Global Duchenne Muscular Dystrophy Revenue and Market Share by Type (2017-2022)
5.3 Global Duchenne Muscular Dystrophy Price by Type (2017-2022)
5.4 Global Duchenne Muscular Dystrophy Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Duchenne Muscular Dystrophy Sales Volume, Revenue and Growth Rate of Deflazacort (2017-2022)
5.4.2 Global Duchenne Muscular Dystrophy Sales Volume, Revenue and Growth Rate of Prednisone (2017-2022)
5.4.3 Global Duchenne Muscular Dystrophy Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL DUCHENNE MUSCULAR DYSTROPHY MARKET ANALYSIS BY APPLICATION
6.1 Global Duchenne Muscular Dystrophy Consumption and Market Share by Application (2017-2022)
6.2 Global Duchenne Muscular Dystrophy Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Duchenne Muscular Dystrophy Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Duchenne Muscular Dystrophy Consumption and Growth Rate of Male (2017-2022)
6.3.2 Global Duchenne Muscular Dystrophy Consumption and Growth Rate of Female (2017-2022)
7 GLOBAL DUCHENNE MUSCULAR DYSTROPHY MARKET FORECAST (2022-2027)
7.1 Global Duchenne Muscular Dystrophy Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Duchenne Muscular Dystrophy Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Duchenne Muscular Dystrophy Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Duchenne Muscular Dystrophy Price and Trend Forecast (2022-2027)
7.2 Global Duchenne Muscular Dystrophy Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Duchenne Muscular Dystrophy Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Duchenne Muscular Dystrophy Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Duchenne Muscular Dystrophy Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Duchenne Muscular Dystrophy Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Duchenne Muscular Dystrophy Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Duchenne Muscular Dystrophy Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Duchenne Muscular Dystrophy Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Duchenne Muscular Dystrophy Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Duchenne Muscular Dystrophy Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Duchenne Muscular Dystrophy Revenue and Growth Rate of Deflazacort (2022-2027)
7.3.2 Global Duchenne Muscular Dystrophy Revenue and Growth Rate of Prednisone (2022-2027)
7.3.3 Global Duchenne Muscular Dystrophy Revenue and Growth Rate of Others (2022-2027)
7.4 Global Duchenne Muscular Dystrophy Consumption Forecast by Application (2022-2027)
7.4.1 Global Duchenne Muscular Dystrophy Consumption Value and Growth Rate of Male(2022-2027)
7.4.2 Global Duchenne Muscular Dystrophy Consumption Value and Growth Rate of Female(2022-2027)
7.5 Duchenne Muscular Dystrophy Market Forecast Under COVID-19
8 DUCHENNE MUSCULAR DYSTROPHY MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Duchenne Muscular Dystrophy Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Duchenne Muscular Dystrophy Analysis
8.6 Major Downstream Buyers of Duchenne Muscular Dystrophy Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Duchenne Muscular Dystrophy Industry
9 PLAYERS PROFILES
9.1 Taiho Pharmaceutical
9.1.1 Taiho Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.1.3 Taiho Pharmaceutical Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Catabasis Pharmaceuticals
9.2.1 Catabasis Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.2.3 Catabasis Pharmaceuticals Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Italfarmaco
9.3.1 Italfarmaco Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.3.3 Italfarmaco Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Santhera Pharmaceuticals/ReveraGen BioPharma
9.4.1 Santhera Pharmaceuticals/ReveraGen BioPharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.4.3 Santhera Pharmaceuticals/ReveraGen BioPharma Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 FibroGen
9.5.1 FibroGen Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.5.3 FibroGen Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Capricor
9.6.1 Capricor Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.6.3 Capricor Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Pfizer
9.7.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.7.3 Pfizer Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Daiichi Sankyo
9.8.1 Daiichi Sankyo Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.8.3 Daiichi Sankyo Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 PTC Therapeutics
9.9.1 PTC Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.9.3 PTC Therapeutics Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Sarepta Therapeutics
9.10.1 Sarepta Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.10.3 Sarepta Therapeutics Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Nippon Shinyaku (NS Pharma)
9.11.1 Nippon Shinyaku (NS Pharma) Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.11.3 Nippon Shinyaku (NS Pharma) Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Duchenne Muscular Dystrophy Market
1.2 Duchenne Muscular Dystrophy Market Segment by Type
1.2.1 Global Duchenne Muscular Dystrophy Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Duchenne Muscular Dystrophy Market Segment by Application
1.3.1 Duchenne Muscular Dystrophy Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Duchenne Muscular Dystrophy Market, Region Wise (2017-2027)
1.4.1 Global Duchenne Muscular Dystrophy Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Duchenne Muscular Dystrophy Market Status and Prospect (2017-2027)
1.4.3 Europe Duchenne Muscular Dystrophy Market Status and Prospect (2017-2027)
1.4.4 China Duchenne Muscular Dystrophy Market Status and Prospect (2017-2027)
1.4.5 Japan Duchenne Muscular Dystrophy Market Status and Prospect (2017-2027)
1.4.6 India Duchenne Muscular Dystrophy Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Duchenne Muscular Dystrophy Market Status and Prospect (2017-2027)
1.4.8 Latin America Duchenne Muscular Dystrophy Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Duchenne Muscular Dystrophy Market Status and Prospect (2017-2027)
1.5 Global Market Size of Duchenne Muscular Dystrophy (2017-2027)
1.5.1 Global Duchenne Muscular Dystrophy Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Duchenne Muscular Dystrophy Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Duchenne Muscular Dystrophy Market
2 INDUSTRY OUTLOOK
2.1 Duchenne Muscular Dystrophy Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Duchenne Muscular Dystrophy Market Drivers Analysis
2.4 Duchenne Muscular Dystrophy Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Duchenne Muscular Dystrophy Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Duchenne Muscular Dystrophy Industry Development
3 GLOBAL DUCHENNE MUSCULAR DYSTROPHY MARKET LANDSCAPE BY PLAYER
3.1 Global Duchenne Muscular Dystrophy Sales Volume and Share by Player (2017-2022)
3.2 Global Duchenne Muscular Dystrophy Revenue and Market Share by Player (2017-2022)
3.3 Global Duchenne Muscular Dystrophy Average Price by Player (2017-2022)
3.4 Global Duchenne Muscular Dystrophy Gross Margin by Player (2017-2022)
3.5 Duchenne Muscular Dystrophy Market Competitive Situation and Trends
3.5.1 Duchenne Muscular Dystrophy Market Concentration Rate
3.5.2 Duchenne Muscular Dystrophy Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL DUCHENNE MUSCULAR DYSTROPHY SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Duchenne Muscular Dystrophy Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Duchenne Muscular Dystrophy Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Duchenne Muscular Dystrophy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Duchenne Muscular Dystrophy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Duchenne Muscular Dystrophy Market Under COVID-19
4.5 Europe Duchenne Muscular Dystrophy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Duchenne Muscular Dystrophy Market Under COVID-19
4.6 China Duchenne Muscular Dystrophy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Duchenne Muscular Dystrophy Market Under COVID-19
4.7 Japan Duchenne Muscular Dystrophy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Duchenne Muscular Dystrophy Market Under COVID-19
4.8 India Duchenne Muscular Dystrophy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Duchenne Muscular Dystrophy Market Under COVID-19
4.9 Southeast Asia Duchenne Muscular Dystrophy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Duchenne Muscular Dystrophy Market Under COVID-19
4.10 Latin America Duchenne Muscular Dystrophy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Duchenne Muscular Dystrophy Market Under COVID-19
4.11 Middle East and Africa Duchenne Muscular Dystrophy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Duchenne Muscular Dystrophy Market Under COVID-19
5 GLOBAL DUCHENNE MUSCULAR DYSTROPHY SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Duchenne Muscular Dystrophy Sales Volume and Market Share by Type (2017-2022)
5.2 Global Duchenne Muscular Dystrophy Revenue and Market Share by Type (2017-2022)
5.3 Global Duchenne Muscular Dystrophy Price by Type (2017-2022)
5.4 Global Duchenne Muscular Dystrophy Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Duchenne Muscular Dystrophy Sales Volume, Revenue and Growth Rate of Deflazacort (2017-2022)
5.4.2 Global Duchenne Muscular Dystrophy Sales Volume, Revenue and Growth Rate of Prednisone (2017-2022)
5.4.3 Global Duchenne Muscular Dystrophy Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL DUCHENNE MUSCULAR DYSTROPHY MARKET ANALYSIS BY APPLICATION
6.1 Global Duchenne Muscular Dystrophy Consumption and Market Share by Application (2017-2022)
6.2 Global Duchenne Muscular Dystrophy Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Duchenne Muscular Dystrophy Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Duchenne Muscular Dystrophy Consumption and Growth Rate of Male (2017-2022)
6.3.2 Global Duchenne Muscular Dystrophy Consumption and Growth Rate of Female (2017-2022)
7 GLOBAL DUCHENNE MUSCULAR DYSTROPHY MARKET FORECAST (2022-2027)
7.1 Global Duchenne Muscular Dystrophy Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Duchenne Muscular Dystrophy Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Duchenne Muscular Dystrophy Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Duchenne Muscular Dystrophy Price and Trend Forecast (2022-2027)
7.2 Global Duchenne Muscular Dystrophy Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Duchenne Muscular Dystrophy Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Duchenne Muscular Dystrophy Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Duchenne Muscular Dystrophy Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Duchenne Muscular Dystrophy Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Duchenne Muscular Dystrophy Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Duchenne Muscular Dystrophy Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Duchenne Muscular Dystrophy Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Duchenne Muscular Dystrophy Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Duchenne Muscular Dystrophy Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Duchenne Muscular Dystrophy Revenue and Growth Rate of Deflazacort (2022-2027)
7.3.2 Global Duchenne Muscular Dystrophy Revenue and Growth Rate of Prednisone (2022-2027)
7.3.3 Global Duchenne Muscular Dystrophy Revenue and Growth Rate of Others (2022-2027)
7.4 Global Duchenne Muscular Dystrophy Consumption Forecast by Application (2022-2027)
7.4.1 Global Duchenne Muscular Dystrophy Consumption Value and Growth Rate of Male(2022-2027)
7.4.2 Global Duchenne Muscular Dystrophy Consumption Value and Growth Rate of Female(2022-2027)
7.5 Duchenne Muscular Dystrophy Market Forecast Under COVID-19
8 DUCHENNE MUSCULAR DYSTROPHY MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Duchenne Muscular Dystrophy Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Duchenne Muscular Dystrophy Analysis
8.6 Major Downstream Buyers of Duchenne Muscular Dystrophy Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Duchenne Muscular Dystrophy Industry
9 PLAYERS PROFILES
9.1 Taiho Pharmaceutical
9.1.1 Taiho Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.1.3 Taiho Pharmaceutical Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Catabasis Pharmaceuticals
9.2.1 Catabasis Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.2.3 Catabasis Pharmaceuticals Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Italfarmaco
9.3.1 Italfarmaco Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.3.3 Italfarmaco Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Santhera Pharmaceuticals/ReveraGen BioPharma
9.4.1 Santhera Pharmaceuticals/ReveraGen BioPharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.4.3 Santhera Pharmaceuticals/ReveraGen BioPharma Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 FibroGen
9.5.1 FibroGen Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.5.3 FibroGen Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Capricor
9.6.1 Capricor Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.6.3 Capricor Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Pfizer
9.7.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.7.3 Pfizer Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Daiichi Sankyo
9.8.1 Daiichi Sankyo Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.8.3 Daiichi Sankyo Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 PTC Therapeutics
9.9.1 PTC Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.9.3 PTC Therapeutics Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Sarepta Therapeutics
9.10.1 Sarepta Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.10.3 Sarepta Therapeutics Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Nippon Shinyaku (NS Pharma)
9.11.1 Nippon Shinyaku (NS Pharma) Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Duchenne Muscular Dystrophy Product Profiles, Application and Specification
9.11.3 Nippon Shinyaku (NS Pharma) Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Duchenne Muscular Dystrophy Product Picture
Table Global Duchenne Muscular Dystrophy Market Sales Volume and CAGR (%) Comparison by Type
Table Duchenne Muscular Dystrophy Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Duchenne Muscular Dystrophy Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Duchenne Muscular Dystrophy Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Duchenne Muscular Dystrophy Industry Development
Table Global Duchenne Muscular Dystrophy Sales Volume by Player (2017-2022)
Table Global Duchenne Muscular Dystrophy Sales Volume Share by Player (2017-2022)
Figure Global Duchenne Muscular Dystrophy Sales Volume Share by Player in 2021
Table Duchenne Muscular Dystrophy Revenue (Million USD) by Player (2017-2022)
Table Duchenne Muscular Dystrophy Revenue Market Share by Player (2017-2022)
Table Duchenne Muscular Dystrophy Price by Player (2017-2022)
Table Duchenne Muscular Dystrophy Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Duchenne Muscular Dystrophy Sales Volume, Region Wise (2017-2022)
Table Global Duchenne Muscular Dystrophy Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Duchenne Muscular Dystrophy Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Duchenne Muscular Dystrophy Sales Volume Market Share, Region Wise in 2021
Table Global Duchenne Muscular Dystrophy Revenue (Million USD), Region Wise (2017-2022)
Table Global Duchenne Muscular Dystrophy Revenue Market Share, Region Wise (2017-2022)
Figure Global Duchenne Muscular Dystrophy Revenue Market Share, Region Wise (2017-2022)
Figure Global Duchenne Muscular Dystrophy Revenue Market Share, Region Wise in 2021
Table Global Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Duchenne Muscular Dystrophy Sales Volume by Type (2017-2022)
Table Global Duchenne Muscular Dystrophy Sales Volume Market Share by Type (2017-2022)
Figure Global Duchenne Muscular Dystrophy Sales Volume Market Share by Type in 2021
Table Global Duchenne Muscular Dystrophy Revenue (Million USD) by Type (2017-2022)
Table Global Duchenne Muscular Dystrophy Revenue Market Share by Type (2017-2022)
Figure Global Duchenne Muscular Dystrophy Revenue Market Share by Type in 2021
Table Duchenne Muscular Dystrophy Price by Type (2017-2022)
Figure Global Duchenne Muscular Dystrophy Sales Volume and Growth Rate of Deflazacort (2017-2022)
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate of Deflazacort (2017-2022)
Figure Global Duchenne Muscular Dystrophy Sales Volume and Growth Rate of Prednisone (2017-2022)
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate of Prednisone (2017-2022)
Figure Global Duchenne Muscular Dystrophy Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Duchenne Muscular Dystrophy Consumption by Application (2017-2022)
Table Global Duchenne Muscular Dystrophy Consumption Market Share by Application (2017-2022)
Table Global Duchenne Muscular Dystrophy Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Duchenne Muscular Dystrophy Consumption Revenue Market Share by Application (2017-2022)
Table Global Duchenne Muscular Dystrophy Consumption and Growth Rate of Male (2017-2022)
Table Global Duchenne Muscular Dystrophy Consumption and Growth Rate of Female (2017-2022)
Figure Global Duchenne Muscular Dystrophy Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Duchenne Muscular Dystrophy Price and Trend Forecast (2022-2027)
Figure USA Duchenne Muscular Dystrophy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Duchenne Muscular Dystrophy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Duchenne Muscular Dystrophy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Duchenne Muscular Dystrophy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Duchenne Muscular Dystrophy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Duchenne Muscular Dystrophy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Duchenne Muscular Dystrophy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Duchenne Muscular Dystrophy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Duchenne Muscular Dystrophy Market Sales Volume Forecast, by Type
Table Global Duchenne Muscular Dystrophy Sales Volume Market Share Forecast, by Type
Table Global Duchenne Muscular Dystrophy Market Revenue (Million USD) Forecast, by Type
Table Global Duchenne Muscular Dystrophy Revenue Market Share Forecast, by Type
Table Global Duchenne Muscular Dystrophy Price Forecast, by Type
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate of Deflazacort (2022-2027)
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate of Deflazacort (2022-2027)
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate of Prednisone (2022-2027)
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate of Prednisone (2022-2027)
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Duchenne Muscular Dystrophy Market Consumption Forecast, by Application
Table Global Duchenne Muscular Dystrophy Consumption Market Share Forecast, by Application
Table Global Duchenne Muscular Dystrophy Market Revenue (Million USD) Forecast, by Application
Table Global Duchenne Muscular Dystrophy Revenue Market Share Forecast, by Application
Figure Global Duchenne Muscular Dystrophy Consumption Value (Million USD) and Growth Rate of Male (2022-2027)
Figure Global Duchenne Muscular Dystrophy Consumption Value (Million USD) and Growth Rate of Female (2022-2027)
Figure Duchenne Muscular Dystrophy Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Taiho Pharmaceutical Profile
Table Taiho Pharmaceutical Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Taiho Pharmaceutical Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure Taiho Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table Catabasis Pharmaceuticals Profile
Table Catabasis Pharmaceuticals Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Catabasis Pharmaceuticals Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure Catabasis Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Italfarmaco Profile
Table Italfarmaco Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Italfarmaco Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure Italfarmaco Revenue (Million USD) Market Share 2017-2022
Table Santhera Pharmaceuticals/ReveraGen BioPharma Profile
Table Santhera Pharmaceuticals/ReveraGen BioPharma Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Santhera Pharmaceuticals/ReveraGen BioPharma Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure Santhera Pharmaceuticals/ReveraGen BioPharma Revenue (Million USD) Market Share 2017-2022
Table FibroGen Profile
Table FibroGen Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure FibroGen Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure FibroGen Revenue (Million USD) Market Share 2017-2022
Table Capricor Profile
Table Capricor Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Capricor Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure Capricor Revenue (Million USD) Market Share 2017-2022
Table Pfizer Profile
Table Pfizer Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure Pfizer Revenue (Million USD) Market Share 2017-2022
Table Daiichi Sankyo Profile
Table Daiichi Sankyo Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Daiichi Sankyo Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure Daiichi Sankyo Revenue (Million USD) Market Share 2017-2022
Table PTC Therapeutics Profile
Table PTC Therapeutics Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure PTC Therapeutics Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure PTC Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Sarepta Therapeutics Profile
Table Sarepta Therapeutics Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sarepta Therapeutics Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure Sarepta Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Nippon Shinyaku (NS Pharma) Profile
Table Nippon Shinyaku (NS Pharma) Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Nippon Shinyaku (NS Pharma) Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure Nippon Shinyaku (NS Pharma) Revenue (Million USD) Market Share 2017-2022
Figure Duchenne Muscular Dystrophy Product Picture
Table Global Duchenne Muscular Dystrophy Market Sales Volume and CAGR (%) Comparison by Type
Table Duchenne Muscular Dystrophy Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Duchenne Muscular Dystrophy Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Duchenne Muscular Dystrophy Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Duchenne Muscular Dystrophy Industry Development
Table Global Duchenne Muscular Dystrophy Sales Volume by Player (2017-2022)
Table Global Duchenne Muscular Dystrophy Sales Volume Share by Player (2017-2022)
Figure Global Duchenne Muscular Dystrophy Sales Volume Share by Player in 2021
Table Duchenne Muscular Dystrophy Revenue (Million USD) by Player (2017-2022)
Table Duchenne Muscular Dystrophy Revenue Market Share by Player (2017-2022)
Table Duchenne Muscular Dystrophy Price by Player (2017-2022)
Table Duchenne Muscular Dystrophy Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Duchenne Muscular Dystrophy Sales Volume, Region Wise (2017-2022)
Table Global Duchenne Muscular Dystrophy Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Duchenne Muscular Dystrophy Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Duchenne Muscular Dystrophy Sales Volume Market Share, Region Wise in 2021
Table Global Duchenne Muscular Dystrophy Revenue (Million USD), Region Wise (2017-2022)
Table Global Duchenne Muscular Dystrophy Revenue Market Share, Region Wise (2017-2022)
Figure Global Duchenne Muscular Dystrophy Revenue Market Share, Region Wise (2017-2022)
Figure Global Duchenne Muscular Dystrophy Revenue Market Share, Region Wise in 2021
Table Global Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Duchenne Muscular Dystrophy Sales Volume by Type (2017-2022)
Table Global Duchenne Muscular Dystrophy Sales Volume Market Share by Type (2017-2022)
Figure Global Duchenne Muscular Dystrophy Sales Volume Market Share by Type in 2021
Table Global Duchenne Muscular Dystrophy Revenue (Million USD) by Type (2017-2022)
Table Global Duchenne Muscular Dystrophy Revenue Market Share by Type (2017-2022)
Figure Global Duchenne Muscular Dystrophy Revenue Market Share by Type in 2021
Table Duchenne Muscular Dystrophy Price by Type (2017-2022)
Figure Global Duchenne Muscular Dystrophy Sales Volume and Growth Rate of Deflazacort (2017-2022)
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate of Deflazacort (2017-2022)
Figure Global Duchenne Muscular Dystrophy Sales Volume and Growth Rate of Prednisone (2017-2022)
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate of Prednisone (2017-2022)
Figure Global Duchenne Muscular Dystrophy Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Duchenne Muscular Dystrophy Consumption by Application (2017-2022)
Table Global Duchenne Muscular Dystrophy Consumption Market Share by Application (2017-2022)
Table Global Duchenne Muscular Dystrophy Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Duchenne Muscular Dystrophy Consumption Revenue Market Share by Application (2017-2022)
Table Global Duchenne Muscular Dystrophy Consumption and Growth Rate of Male (2017-2022)
Table Global Duchenne Muscular Dystrophy Consumption and Growth Rate of Female (2017-2022)
Figure Global Duchenne Muscular Dystrophy Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Duchenne Muscular Dystrophy Price and Trend Forecast (2022-2027)
Figure USA Duchenne Muscular Dystrophy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Duchenne Muscular Dystrophy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Duchenne Muscular Dystrophy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Duchenne Muscular Dystrophy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Duchenne Muscular Dystrophy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Duchenne Muscular Dystrophy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Duchenne Muscular Dystrophy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Duchenne Muscular Dystrophy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Duchenne Muscular Dystrophy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Duchenne Muscular Dystrophy Market Sales Volume Forecast, by Type
Table Global Duchenne Muscular Dystrophy Sales Volume Market Share Forecast, by Type
Table Global Duchenne Muscular Dystrophy Market Revenue (Million USD) Forecast, by Type
Table Global Duchenne Muscular Dystrophy Revenue Market Share Forecast, by Type
Table Global Duchenne Muscular Dystrophy Price Forecast, by Type
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate of Deflazacort (2022-2027)
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate of Deflazacort (2022-2027)
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate of Prednisone (2022-2027)
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate of Prednisone (2022-2027)
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Duchenne Muscular Dystrophy Market Consumption Forecast, by Application
Table Global Duchenne Muscular Dystrophy Consumption Market Share Forecast, by Application
Table Global Duchenne Muscular Dystrophy Market Revenue (Million USD) Forecast, by Application
Table Global Duchenne Muscular Dystrophy Revenue Market Share Forecast, by Application
Figure Global Duchenne Muscular Dystrophy Consumption Value (Million USD) and Growth Rate of Male (2022-2027)
Figure Global Duchenne Muscular Dystrophy Consumption Value (Million USD) and Growth Rate of Female (2022-2027)
Figure Duchenne Muscular Dystrophy Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Taiho Pharmaceutical Profile
Table Taiho Pharmaceutical Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Taiho Pharmaceutical Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure Taiho Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table Catabasis Pharmaceuticals Profile
Table Catabasis Pharmaceuticals Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Catabasis Pharmaceuticals Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure Catabasis Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Italfarmaco Profile
Table Italfarmaco Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Italfarmaco Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure Italfarmaco Revenue (Million USD) Market Share 2017-2022
Table Santhera Pharmaceuticals/ReveraGen BioPharma Profile
Table Santhera Pharmaceuticals/ReveraGen BioPharma Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Santhera Pharmaceuticals/ReveraGen BioPharma Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure Santhera Pharmaceuticals/ReveraGen BioPharma Revenue (Million USD) Market Share 2017-2022
Table FibroGen Profile
Table FibroGen Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure FibroGen Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure FibroGen Revenue (Million USD) Market Share 2017-2022
Table Capricor Profile
Table Capricor Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Capricor Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure Capricor Revenue (Million USD) Market Share 2017-2022
Table Pfizer Profile
Table Pfizer Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure Pfizer Revenue (Million USD) Market Share 2017-2022
Table Daiichi Sankyo Profile
Table Daiichi Sankyo Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Daiichi Sankyo Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure Daiichi Sankyo Revenue (Million USD) Market Share 2017-2022
Table PTC Therapeutics Profile
Table PTC Therapeutics Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure PTC Therapeutics Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure PTC Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Sarepta Therapeutics Profile
Table Sarepta Therapeutics Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sarepta Therapeutics Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure Sarepta Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Nippon Shinyaku (NS Pharma) Profile
Table Nippon Shinyaku (NS Pharma) Duchenne Muscular Dystrophy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Nippon Shinyaku (NS Pharma) Duchenne Muscular Dystrophy Sales Volume and Growth Rate
Figure Nippon Shinyaku (NS Pharma) Revenue (Million USD) Market Share 2017-2022
